Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects

被引：66

作者：

Li, Tianhang ^{[1
]}

Liu, Tianyao ^{[1
]}

Zhu, Wenjie ^{[1
]}

Xie, Shangxun ^{[1
]}

Zhao, Zihan ^{[1
]}

Feng, Baofu ^{[1
]}

Guo, Hongqian ^{[1
]}

Yang, Rong ^{[1
]}

机构：

[1] Nanjing Univ, Affiliated Hosp, Sch Med, Nanjing Drum Tower Hosp,Inst Urol,Dept Urol, Zhongshan Rd 321, Nanjing 210008, Peoples R China

来源：

CLINICAL MEDICINE INSIGHTS-ONCOLOGY | 2021年 / 15卷

基金：

中国国家自然科学基金;

关键词：

Myeloid; derived suppressor cells; ICB; PD-(L) 1; TME; immune escape; SQUAMOUS-CELL CARCINOMA; TUMOR-ASSOCIATED MACROPHAGES; LIGAND; EXPRESSION; SUPPRESSOR-CELLS; MYELOID CELLS; MUTATIONAL BURDEN; INDOLEAMINE 2,3-DIOXYGENASE; ACQUIRED-RESISTANCE; CTLA-4; BLOCKADE; DENDRITIC CELLS;

D O I：

10.1177/11795549211035540

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immune-checkpoint blockade (ICB) demonstrated inspiring effect and great promise in anti-cancer therapy. However, many obstacles, such as drug resistance and difficulty in patient selection, limited the efficacy of ICB therapy and awaited to be overcome. By timely identification and intervention of the key immune-suppressive promotors in the tumor microenvironment (TME), we may better understand the mechanisms of cancer immune-escape and use novel strategies to enhance the therapeutic effect of ICB. Myeloid-derived suppressor cell (MDSC) is recognized as a major immune suppressor in the TME. In this review, we summarized the roles MDSC played in the cancer context, focusing on its negative biologic functions in ICB therapy, discussed the strategies targeted on MDSC to optimize the diagnosis and therapy process of ICB and improve the efficacy of ICB therapy against malignancies.

引用

页数：14

共 187 条

[21] Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells [J].

Curti, Antonio ;

Pandolfi, Simona ;

Valzasina, Barbara ;

Aluigi, Michela ;

Isidori, Alessandro ;

Ferri, Elisa ;

Salvestrini, Valentina ;

Bonanno, Giuseppina ;

Rutella, Sergio ;

Durelli, Ilaria ;

Horenstein, Alberto L. ;

Fiore, Francesca ;

Massaia, Massimo ;

Colombo, Mario P. ;

Baccarani, Michele ;

Lemoli, Roberto M. .

BLOOD, 2007, 109 (07) :2871-2877

[22] Cisplatin in cancer therapy: Molecular mechanisms of action [J].

Dasari, Shaloam ;

Tchounwou, Paul Bernard .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 740 :364-378

[23] Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma [J].

Daud, Adil I. ;

Wolchok, Jedd D. ;

Robert, Caroline ;

Hwu, Wen-Jen ;

Weber, Jeffrey S. ;

Ribas, Antoni ;

Hodi, F. Stephen ;

Joshua, Anthony M. ;

Kefford, Richard ;

Hersey, Peter ;

Joseph, Richard ;

Gangadhar, Tara C. ;

Dronca, Roxana ;

Patnaik, Amita ;

Zarour, Hassane ;

Roach, Charlotte ;

Toland, Grant ;

Lunceford, Jared K. ;

Li, Xiaoyun Nicole ;

Emancipator, Kenneth ;

Dolled-Filhart, Marisa ;

Kang, S. Peter ;

Ebbinghaus, Scot ;

Hamid, Omid .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (34) :4102-+

[24] Cancer Epigenetics: From Mechanism to Therapy [J].

Dawson, Mark A. ;

Kouzarides, Tony .

CELL, 2012, 150 (01) :12-27

[25] Macrophages as regulators of tumour immunity and immunotherapy [J].

DeNardo, David G. ;

Ruffell, Brian .

NATURE REVIEWS IMMUNOLOGY, 2019, 19 (06) :369-382

[26] Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy [J].

DeNardo, David G. ;

Brennan, Donal J. ;

Rexhepaj, Elton ;

Ruffell, Brian ;

Shiao, Stephen L. ;

Madden, Stephen F. ;

Gallagher, William M. ;

Wadhwani, Nikhil ;

Keil, Scott D. ;

Junaid, Sharfaa A. ;

Rugo, Hope S. ;

Hwang, E. Shelley ;

Jirstroem, Karin ;

West, Brian L. ;

Coussens, Lisa M. .

CANCER DISCOVERY, 2011, 1 (01) :54-67

[27] Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis [J].

Deng, Z. ;

Rong, Y. ;

Teng, Y. ;

Zhuang, X. ;

Samykutty, A. ;

Mu, J. ;

Zhang, L. ;

Cao, P. ;

Yan, J. ;

Miller, D. ;

Zhang, H-G .

ONCOGENE, 2017, 36 (05) :639-651

[28] Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus [J].

Dong, Guanjun ;

Yang, Yonghong ;

Li, Xuehui ;

Yao, Xiaoying ;

Zhu, Yuzhen ;

Zhang, Hui ;

Wang, Haiyan ;

Ma, Qun ;

Zhang, Junfeng ;

Shi, Hui ;

Ning, Zhaochen ;

Yan, Fenglian ;

Zhai, Weiwei ;

Dai, Jun ;

Li, Zhihua ;

Li, Chunxia ;

Ming, Jiankuo ;

Xue, Qingjie ;

Meng, Xiangzhi ;

Si, Chuanping ;

Xiong, Huabao .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (01)

[29] Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer [J].

Dong, Xue ;

Pan, Pei ;

Zheng, Di-Wei ;

Bao, Peng ;

Zeng, Xuan ;

Zhang, Xian-Zheng .

SCIENCE ADVANCES, 2020, 6 (20)

[30] Expression Profile Analysis of m6A RNA Methylation Regulators Indicates They Are Immune Signature Associated and Can Predict Survival in Kidney Renal Cell Carcinoma [J].

Fang, Jiuyuan ;

Hu, Mingyang ;

Sun, Yan ;

Zhou, Sijie ;

Li, Huixiang .

DNA AND CELL BIOLOGY, 2020, 39 (12) :2194-2211

← 1 2 3 4 5 6 7 8 9 10 →